Chemical Formula: C7H8N4O3

Chemical Formula C7H8N4O3

Found 38 metabolite its formula value is C7H8N4O3

1,7-dimethylurate

2,8-dihydroxy-1,7-dimethyl-6,7-dihydro-1H-purin-6-one

C7H8N4O3 (196.0596378)


1,7 dimethyluric acid is the major urinary caffeine metabolites that is produced in the human body. 1,7 dimethyluric acid is formed during metabolism of caffeine and the process is catalyzed primarily by CYP2A6. (PMID: 18715882) [HMDB] 1,7-Dimethyluric acid is the major urinary caffeine metabolite that is produced in the human body. 1,7-Dimethyluric acid is formed during caffeine metabolism and the process is catalyzed primarily by CYP2A6 (PMID: 18715882).

   

3,7-Dimethyluric acid

3,7-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C7H8N4O3 (196.0596378)


3,7-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 3,7-Dimethyluric is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152) [HMDB] 3,7-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 3,7-Dimethyluric is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis (PMID:11712316, 15833286, 3506820, 15013152).

   

1,3-dimethylurate

1,3-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C7H8N4O3 (196.0596378)


1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152, 4039734) [HMDB] 1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID:11712316, 15833286, 3506820, 15013152, 4039734). 1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi.

   

1,9-Dimethyluric acid

1,9-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C7H8N4O3 (196.0596378)


1,9-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 1,9-Methyluracil is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152) [HMDB] 1,9-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 1,9-Methyluracil is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID:11712316, 15833286, 3506820, 15013152).

   

3,9-Dimethyluric acid

3,9-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C7H8N4O3 (196.0596378)


3,9-Dimethyluric acid is involved in purine oxidation pathways. Reevaluation of products derived from 3,9-dimethyluric acid in a chlorination-reductive dechlorinaton sequence has demonstrated unequivocally that they are not purines.(PMID 14601976)

   

7,9-Dimethyluric acid

7,9-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C7H8N4O3 (196.0596378)


7,9-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 7,9-Dimethyluracil is one of the purine component in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. (PMID: 11712316, 15833286, 3506820) [HMDB] 7,9-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 7,9-Dimethyluracil is one of the purine component in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. (PMID: 11712316, 15833286, 3506820).

   

1,3-Dimethylurate

1,3-Dimethyluric acid

C7H8N4O3 (196.0596378)


Acquisition and generation of the data is financially supported in part by CREST/JST. 1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi.

   

1,9-Dimethyluric acid

7,9-dihydro-1,9-Dimethyl-1H-purine-2,6,8(3H)-trione

C7H8N4O3 (196.0596378)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.252 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.253 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.246 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.247

   

1,3-Dimethyluric acid

1,3-Dimethyluric acid

C7H8N4O3 (196.0596378)


An oxopurine that is 7,9-dihydro-1H-purine-2,6,8(3H)-trionesubstituted by methyl groups at N-1 and N-3. 1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi.

   

3,7-Dimethyluric acid

3,7-Dimethyluric acid

C7H8N4O3 (196.0596378)


An oxopurine that is 7,9-dihydro-1H-purine-2,6,8(3H)-trione substituted by methyl groups at N-3 and N-7.

   

1,7-Dimethyluric acid

1,7-Dimethyluric acid

C7H8N4O3 (196.0596378)


An oxopurine that is 7,9-dihydro-1H-purine-2,6,8(3H)-trione substituted by methyl groups at N-1 and N-7. It is a metabolite of caffeine and is often found in human urine samples.

   

1,3-Dimethyluric acid; LC-tDDA; CE10

1,3-Dimethyluric acid; LC-tDDA; CE10

C7H8N4O3 (196.0596378)


   

1,3-Dimethyluric acid; LC-tDDA; CE20

1,3-Dimethyluric acid; LC-tDDA; CE20

C7H8N4O3 (196.0596378)


   

1,3-Dimethyluric acid; LC-tDDA; CE30

1,3-Dimethyluric acid; LC-tDDA; CE30

C7H8N4O3 (196.0596378)


   

1,3-Dimethyluric acid; LC-tDDA; CE40

1,3-Dimethyluric acid; LC-tDDA; CE40

C7H8N4O3 (196.0596378)


   

1,7-Dimethyluric acid; LC-tDDA; CE10

1,7-Dimethyluric acid; LC-tDDA; CE10

C7H8N4O3 (196.0596378)


   

1,7-Dimethyluric acid; LC-tDDA; CE20

1,7-Dimethyluric acid; LC-tDDA; CE20

C7H8N4O3 (196.0596378)


   

1,7-Dimethyluric acid; LC-tDDA; CE30

1,7-Dimethyluric acid; LC-tDDA; CE30

C7H8N4O3 (196.0596378)


   

1,7-Dimethyluric acid; LC-tDDA; CE40

1,7-Dimethyluric acid; LC-tDDA; CE40

C7H8N4O3 (196.0596378)


   

1,7-Dimethyluric acid; AIF; CE10; CorrDec

1,7-Dimethyluric acid; AIF; CE10; CorrDec

C7H8N4O3 (196.0596378)


   

1,7-Dimethyluric acid; AIF; CE30; CorrDec

1,7-Dimethyluric acid; AIF; CE30; CorrDec

C7H8N4O3 (196.0596378)


   

1,7-Dimethyluric acid; AIF; CE0; MS2Dec

1,7-Dimethyluric acid; AIF; CE0; MS2Dec

C7H8N4O3 (196.0596378)


   

1,7-Dimethyluric acid; AIF; CE10; MS2Dec

1,7-Dimethyluric acid; AIF; CE10; MS2Dec

C7H8N4O3 (196.0596378)


   

1,7-Dimethyluric acid; AIF; CE30; MS2Dec

1,7-Dimethyluric acid; AIF; CE30; MS2Dec

C7H8N4O3 (196.0596378)


   

1,3-Dimethyluric acid; AIF: CE0; CorrDec

1,3-Dimethyluric acid; AIF: CE0; CorrDec

C7H8N4O3 (196.0596378)


   

1,3-Dimethyluric acid; AIF: CE10; CorrDec

1,3-Dimethyluric acid; AIF: CE10; CorrDec

C7H8N4O3 (196.0596378)


   

1,3-Dimethyluric acid; AIF: CE30; CorrDec

1,3-Dimethyluric acid; AIF: CE30; CorrDec

C7H8N4O3 (196.0596378)


   

1,3-Dimethyluric acid; AIF: CE0; MS2Dec

1,3-Dimethyluric acid; AIF: CE0; MS2Dec

C7H8N4O3 (196.0596378)


   

1,3-Dimethyluric acid; AIF: CE10; MS2Dec

1,3-Dimethyluric acid; AIF: CE10; MS2Dec

C7H8N4O3 (196.0596378)


   

1,3-Dimethyluric acid; AIF: CE30; MS2Dec

1,3-Dimethyluric acid; AIF: CE30; MS2Dec

C7H8N4O3 (196.0596378)


   

Oxytheophylline

1,3-dimethyl-7,9-dihydropurine-2,6,8-trione

C7H8N4O3 (196.0596378)


1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi.

   

7,9-Dimethyluric acid

7,9-dihydro-7,9-Dimethyl-1H-purine-2,6,8(3H)-trione

C7H8N4O3 (196.0596378)


   

3,9-dimethyluric acid

3,9-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C7H8N4O3 (196.0596378)


   

2-amino-5-nitrobenzohydrazide

2-amino-5-nitrobenzohydrazide

C7H8N4O3 (196.0596378)


   

2-METHYL-5-NITRONICOTINOHYDRAZIDE

2-METHYL-5-NITRONICOTINOHYDRAZIDE

C7H8N4O3 (196.0596378)


   

7,9-Dihydro-3,9-dimethyl-1H-purine-2,6,8(3H)-trione

7,9-Dihydro-3,9-dimethyl-1H-purine-2,6,8(3H)-trione

C7H8N4O3 (196.0596378)


   

7,9-dihydro-7,9-Dimethyl-1H-purine-2,6,8(3H)-trione

7,9-dihydro-7,9-Dimethyl-1H-purine-2,6,8(3H)-trione

C7H8N4O3 (196.0596378)


   

Dimethyluric acid

Dimethyluric acid

C7H8N4O3 (196.0596378)